TABLE 2.
Drug | MICa (μg/ml) |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Wild type | ΔmrcB | ΔdacA | ΔycfM | ΔybgF | ΔdapF | ΔdksA | ΔtolC | Susceptibility breakpoint | Resistance breakpoint | |
FOX | 32 | 8 | 32 | 16 | 16 | 2 | 16 | 32 | ≤8 | ≥32 |
CTX | 8 | 4 | 8 | 16 | 8 | 2 | 4 | 8 | ≤1 | ≥4 |
CAZ | 32 | 8 | 32 | 32 | 32 | 32 | 16 | 32 | ≤4 | ≥16 |
MICs equal to or below the CLSI susceptibility breakpoints for Enterobacteriaceae (37) are indicated in boldface. The MICs of drugs for which individual gene deletion resulted in a synergistic effect (interaction index ≤ 0.25) are underlined.